Hovione

Hovione, established in 1959, is a prominent player in the pharmaceutical and healthcare industries, specializing in the manufacturing of FDA-approved active pharmaceutical ingredients (APIs) and drug product intermediates. With a strong foundation in chemical process development and formulation, the company leverages its expertise to provide integrated contract development and manufacturing services. Hovione's commitment to quality and compliance is evident in its production of essential pharmaceutical chemicals and drug substances, serving a global client base. The company's URL is www.hovione.com, providing access to detailed service offerings and company information.

Operating with a workforce of 1,000-5,000 employees across 5 locations, Hovione offers a comprehensive suite of services including contract formulation, process development, and specialized manufacturing techniques like spray drying. Their product portfolio encompasses a wide range of pharmaceutical intermediates and APIs, designed to meet stringent regulatory requirements. The company's technical capabilities extend to inhalation drug development and the production of complex chemical compounds. For insights into the people driving these advancements, users can explore Meet Hovione's team.

Hovione's extensive experience, dating back to its founding, positions it as a reliable partner for pharmaceutical innovation. The company focuses on delivering cost-effective and compliant solutions, from early-stage development through to commercial manufacturing. Their expertise in areas such as powder handling, particle engineering, and GMP-compliant processes ensures the delivery of high-quality pharmaceutical products. Hovione's operational scale and technical depth enable them to manage complex projects and contribute significantly to the pharmaceutical supply chain.